Use of antibacterial agents in acute exacerbation of chronic obstructive pulmonary disease——Interpretation of COPD guidelines

ZHOU Qing-tao,HE Bei
DOI: https://doi.org/10.3969/j.issn.1672-8157.2011.02.001
2011-01-01
Abstract:Chronic obstructive pulmonary disease(COPD) is one of the major causes leading to chronic morbidity and mortality throughout the world.An acute exacerbation of COPD is defined as an event in the natural course of the disease characterized by an acute change in patient's baseline dyspnea,cough and/or sputum beyond day-to-day variability sufficient to warrant a change in the therapy.COPD exacerbation has serious negative impacts on the lung function and life quality of patients.The most common cause for exacerbation is the infection of tracheobronchial tree,patients can get benefit from rational use of antibacterial agents.Antibacterial agents can be empirically selected according to the severity of acute exacerbation,risk factors that affect turnover,risk factors for infection of P.aeruginosa,and the structure and resistance of pathogenic bacteria.Beta-lactam/beta-lactamase inhibitor combinations,cephalosporins and fluoroquinolones are the most appropriate antibacterial agents for acute exacerbation of COPD.If the result of initial treatment didn't work well,the treatment should be adjusted according to the results of bacterial culture and antibacterial susceptibility testing.C-reactive protein and procalcitonin may help guide the use of antibacterial agents in COPD exacerbation.
What problem does this paper attempt to address?